Bright Light Therapy on Post-stroke Insomniawith Post-stroke Insomnia

• Status: Completed
• Trial end date: 2018-08-01
• Target enrollment: 56
• Participant gender: All

Summary

The objective of this study was to determine the effectiveness of bright light therapy as a treatment for early, mild-to-moderate stroke patients with post-stroke insomnia.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Inha University Hospital

Criteria

Inclusion Criteria:

• first occurrence of stroke for the patient

• matched International Classification of Diseases (ICD)-10 codes (nontraumatic subarachnoid hemorrhage [I60], nontraumatic intracerebral hemorrhage [I61], other and unspecified nontraumatic intracranial hemorrhage [I62], or cerebral infarction [I63]) (World Health Organization, 1997)

• mild-to-moderate stroke (the National Institutes of Health Stroke Scale ≤14)

• age ≥18 years

• satisfactory cognitive function

• post-stroke insomnia.

Exclusion Criteria:

• Mini Mental State Examination (MMSE) score of ≤10

• recurrent stroke

• aphasia

• transient ischemic attack

• schizophrenia, bipolar disorder, mood disorder, previous insomnia disorder, or dementia before stroke

• taking sleeping pills or antidepressants for 5 or more days within a 6-month timespan before the onset of stroke

• post-stroke delirium

• a National Institutes of Health Stroke Scale score ≥ 14

• previous eye disease or post-stroke eye disease

• severe auditory impairment

• the use of psychotropic medications (hypnotics, benzodiazepine, benzodiazepine agonists, antidepressants [mirtazapine or trazodone] or antipsychotics)